Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

T M Kuijper; J J Luime; P H P de Jong; A H Gerards; D van Zeben; I Tchetverikov; P B J de Sonnaville; M V van Krugten; B A Grillet; J M W Hazes; A E A M Weel

doi:10.1136/annrheumdis-2016-209272

Article info

Clinical and epidemiological research

Concise report

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

Authors

T M Kuijper Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands Department of Rheumatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
J J Luime Department of Rheumatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
P H P de Jong Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands PubMed articles Google scholar articles
A H Gerards Department of Rheumatology, Vlietland Hospital, Schiedam, The Netherlands PubMed articles Google scholar articles
D van Zeben Department of Rheumatology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands PubMed articles Google scholar articles
I Tchetverikov Department of Rheumatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands PubMed articles Google scholar articles
P B J de Sonnaville Department of Rheumatology, Admiraal de Ruyter Hospital, Goes, The Netherlands Reumazorg Zuid West Nederland, Goes, The Netherlands PubMed articles Google scholar articles
M V van Krugten Department of Rheumatology, Admiraal de Ruyter Hospital, Goes, The Netherlands Reumazorg Zuid West Nederland, Vlissingen, The Netherlands PubMed articles Google scholar articles
B A Grillet Department of Rheumatology, Admiraal de Ruyter Hospital, Vlissingen, The Netherlands Department of Rheumatology, ZorgSaam Hospital, Terneuzen, The Netherlands Reumazorg Zuid West Nederland, Terneuzen, The Netherlands PubMed articles Google scholar articles
J M W Hazes Department of Rheumatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles
A E A M Weel Department of Rheumatology, Maasstad Hospital, Rotterdam, The Netherlands Department of Rheumatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands PubMed articles Google scholar articles

Correspondence to T M Kuijper, Department of Rheumatology, Maasstad Hospital, Maasstadweg 21, Rotterdam 3079 DZ, The Netherlands; kuijpert{at}maasstadziekenhuis.nl

View Full Text

Citation

Kuijper TM, Luime JJ, de Jong PHP, et al

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial

Annals of the Rheumatic Diseases 2016;75:2119-2123.

Publication history

Received January 27, 2016
Revised May 13, 2016
Accepted May 17, 2016
First published June 9, 2016.

Online issue publication

November 10, 2016

Article Versions

Previous version (9 June 2016).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password